MARKET

OMCL

OMCL

Omnicell Com
NASDAQ
27.25
+0.94
+3.57%
After Hours: 27.25 0 0.00% 16:02 02/23 EST
OPEN
26.03
PREV CLOSE
26.31
HIGH
27.42
LOW
25.98
VOLUME
444.52K
TURNOVER
0
52 WEEK HIGH
77.14
52 WEEK LOW
25.98
MARKET CAP
1.24B
P/E (TTM)
-60.4749
1D
5D
1M
3M
1Y
5Y
Is It Too Late To Consider Buying Omnicell, Inc. (NASDAQ:OMCL)?
Omnicell, Inc. Is currently trading at a low price of US$26.31 on the NASDAQGS. The small-cap company is expected to grow its earnings over the next few years by 74%. Omnicell is currently undervalued, but its future growth isn't fully reflected in the share price. The company's share price could be a good opportunity to buy the stock now. OmniceLL's intrinsic value is $41.63 but the stock is currently valued at US$25.
Simply Wall St · 2d ago
Omnicell Is Building A Strong Moat
Omnicell is building a strong moat in the medication dispensing market. The company's revenues are expected to return to the growth path in 2025. Revenues decreased in 2023 and will continue declining in 2024 as healthcare centers are reducing their capital investments. Recent workforce reductions should stabilize margins in the short term. The balance sheet is strong enough to cushion a big portion of the expected impact of convertible notes expiring in 2024. Omnicell's share price has fallen 85% in recent months.
Seeking Alpha · 3d ago
Weekly Report: what happened at OMCL last week (0212-0216)?
Weekly Report · 6d ago
Vivid Seats, Atmus Filtration & Visteon are some of the top small cap value stocks - BofA
Vivid Seats, Atmus Filtration & Visteon are some of the top small cap value stocks - BofA. Stocks that focus on value style are historically cheap compared to the growth stocks. The value stocks tend to outperform when the Federal Reserve stops hiking interest rates.
Seeking Alpha · 02/15 17:09
Omnicell (OMCL) Q4 Earnings Top Estimates, Gross Margin Down
NASDAQ · 02/12 12:43
Weekly Report: what happened at OMCL last week (0205-0209)?
Weekly Report · 02/12 09:20
Benchmark Maintains Buy on Omnicell, Lowers Price Target to $38
Benzinga · 02/09 19:34
Wells Fargo Maintains Equal-Weight on Omnicell, Lowers Price Target to $26
Benzinga · 02/09 14:30
More
About OMCL
Omnicell, Inc. is a provider of medication management solutions and adherence tools for health systems and pharmacies. The Company is focused on transforming the pharmacy care delivery model through automation designed to replace manual, error-prone processes, combined with a single, cloud-based platform and advanced services offerings. The Company's point-of-care automation solutions are designed to improve clinician workflows in patient care areas of the healthcare system, such as nursing units, patient wards, operating rooms, and emergency departments. The Company's Omnicell Interface Software provides interface and integration between its medication-use products or its supply products and a healthcare facility's in-house information management systems. The Company's Central Pharmacy IV Compounding Service offers a range of service model inclusive of IV robotic technology, data analytic tools, and clinical support for insourced sterile compounding programs.

Webull offers Omnicell Inc stock information, including NASDAQ: OMCL real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, OMCL stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading OMCL stock methods without spending real money on the virtual paper trading platform.